Related Experiment Video
Updated: Jul 4, 2026

Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification (BiCAP)
Published on: June 15, 2018
Identification of nucleolin as new ErbB receptors- interacting protein
Ayelet Di Segni1, Keren Farin, Ronit Pinkas-Kramarski
1Department of Neurobiology, Tel-Aviv University, Ramat-Aviv, Israel.
Background:
The ErbB receptor tyrosine kinases are major contributors to malignant transformation. These receptors are frequently overexpressed in a variety of human carcinomas. The role of the ErbB receptors and their ligands in carcinomas and the mechanism by which their overexpression leads to cancer development is still unclear. Ligand binding to specific ErbB receptor is followed by receptor dimerization, phosphorylation and recruitment of SH2 containing cytoplasmic proteins, which initiate the cascade of signaling events. Nevertheless, increasing data suggest that there are non-phosphorylated receptor-substrate interactions that may affect ErbB-mediated responses.
Methodology/Principal Findings:
In the present study, using GST-ErbB4 fusion protein pull down assay and mass spectroscopic analysis, we have found the ErbB receptors interact with nucleolin via their cytoplasmic tail. Nucleolin is a ubiquitous, nonhistone, nucleolar, multifunctional phosphoprotein that is also overexpressed in cancer cells. Our results demonstrate that overexpression of ErbB1 and nucleolin may lead to receptor dimerization, phosphorylation and to anchorage independent growth.
Conclusions/Significance:
The oncogenic potential of ErbB depends on receptor levels and activation. Our results suggest that nucleolin may affect ErbB dimerization and activation leading to enhanced cell growth.
Insights
ErbB receptors interact with nucleolin, a protein overexpressed in cancer. This interaction may drive cancer cell growth by promoting ErbB receptor dimerization and activation, highlighting a new therapeutic target.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Signal Transduction
Background:
- ErbB receptor tyrosine kinases are crucial in cancer development and frequently overexpressed in carcinomas.
- The precise mechanisms linking ErbB overexpression to cancer remain incompletely understood.
- Non-phosphorylated receptor-substrate interactions are increasingly recognized as important in ErbB signaling.
Purpose of the Study:
- To investigate novel interactions of ErbB receptors beyond canonical signaling pathways.
- To identify potential non-phosphorylated substrates that modulate ErbB receptor activity.
Main Methods:
- GST-ErbB4 fusion protein pull-down assays.
- Mass spectroscopic analysis to identify interacting proteins.
- Investigated the functional consequences of ErbB and nucleolin co-overexpression.
Main Results:
- Identified nucleolin as a binding partner of ErbB receptors, interacting via the cytoplasmic tail.
- Nucleolin is a nucleolar phosphoprotein also found to be overexpressed in cancer cells.
- Co-overexpression of ErbB1 and nucleolin promoted receptor dimerization, phosphorylation, and anchorage-independent growth.
Conclusions:
- Nucleolin interacts with ErbB receptors, suggesting a role in cancer progression.
- Nucleolin may influence ErbB receptor dimerization and activation, contributing to enhanced cell growth.
- Targeting the ErbB-nucleolin interaction could offer a novel therapeutic strategy in carcinomas.
Related Concept Videos
The Nucleolus
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Nuclear Localization Signals and Import
Regulation of Nuclear Protein Sorting
ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...

